Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1176
Fidelity High Dividend ETF
FDVV
$10.3B
| $164M | 0.01% |
2,713,339
+84,614
| +3% | +$5.03M |
2018 Q4
30 quarters
|
|
1177
Guardant Health
GH
$22.5B
| $163M | 0.01% |
1,088,477
-398,847
| -27% | -$43.4M |
2018 Q4
30 quarters
|
|
1178
First Trust Technology AlphaDEX Fund
FXL
$2.81B
| $163M | 0.01% |
750,232
+68,961
| +10% | +$13.4M |
2013 Q2
52 quarters
|
|
1179
Solaris Energy Infrastructure
SEI
$4.26B
| $163M | 0.01% |
2,024,283
+316,828
| +19% | +$22.6M |
2017 Q2
36 quarters
|
|
1180
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.35B
| $163M | 0.01% |
1,111,571
+30,282
| +3% | +$4.2M |
2013 Q2
52 quarters
|
|
1181
Talen Energy Corp
TLN
$16.7B
| $163M | 0.01% |
423,332
+16,834
| +4% | +$6.17M |
2024 Q3
7 quarters
|
|
1182
Core Scientific
CORZ
$4.54B
| $162M | 0.01% |
6,338,943
+2,866,937
| +83% | +$67.5M |
2024 Q1
9 quarters
|
|
1183
NGL Energy Partners
NGL
$1.85B
| $162M | 0.01% |
10,180,003
+386,178
| +4% | +$6M |
2013 Q2
52 quarters
|
|
1184
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.29B
| $161M | 0.01% |
1,496,947
-114,398
| -7% | -$11.9M |
2013 Q2
52 quarters
|
|
1185
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $161M | 0.01% |
589,146
-5,599
| -0.9% | -$1.49M |
2013 Q2
52 quarters
|
|
1186
Zscaler
ZS
$35.7B
| $160M | 0.01% |
1,136,698
-145,166
| -11% | -$20.2M |
2018 Q1
33 quarters
|
|
1187
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.5B
| $160M | 0.01% |
4,036,172
+260,590
| +7% | +$10.5M |
2016 Q2
40 quarters
|
|
1188
HF Sinclair
DINO
$22B
| $160M | 0.01% |
2,298,249
-74,536
| -3% | -$4.96M |
2013 Q2
52 quarters
|
|
1189
iShares Treasury Floating Rate Bond ETF
TFLO
$7.07B
| $160M | 0.01% |
3,160,243
-478,627
| -13% | -$24.2M |
2014 Q4
46 quarters
|
|
1190
Stifel
SF
$10.3B
| $160M | 0.01% |
2,290,873
+316,245
| +16% | +$23.6M |
2013 Q2
52 quarters
|
|
1191
Teck Resources
TECK
$32.2B
| $160M | 0.01% |
2,685,902
-167,440
| -6% | -$10.2M |
2013 Q2
52 quarters
|
|
1192
Kanzhun
BZ
$7.16B
| $160M | 0.01% |
12,405,907
+823,348
| +7% | +$11.3M |
2021 Q2
20 quarters
|
|
1193
CSW Industrials
CSW
$4.74B
| $160M | 0.01% |
573,678
-21,770
| -4% | -$6.04M |
2015 Q4
42 quarters
|
|
1194
Franco-Nevada
FNV
$46.3B
| $160M | 0.01% |
765,677
-46,173
| -6% | -$10.8M |
2013 Q2
52 quarters
|
|
1195
ESCO Technologies
ESE
$6.5B
| $159M | 0.01% |
454,821
-11,570
| -2% | -$3.62M |
2013 Q3
51 quarters
|
|
1196
East-West Bancorp
EWBC
$17.3B
| $159M | 0.01% |
1,231,251
+39,291
| +3% | +$4.83M |
2013 Q2
52 quarters
|
|
1197
Dr. Reddy's Laboratories
RDY
$10.8B
| $158M | 0.01% |
10,936,320
+1,564,726
| +17% | +$21.1M |
2013 Q2
52 quarters
|
|
1198
Sprott Physical Gold
PHYS
$14.9B
| $158M | 0.01% |
5,242,209
-295,553
| -5% | -$10.1M |
2013 Q2
52 quarters
|
|
1199
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.36B
| $158M | 0.01% |
10,387,693
-314,938
| -3% | -$4.53M |
2013 Q2
52 quarters
|
|
1200
BorgWarner
BWA
$12B
| $158M | 0.01% |
2,375,283
+82,115
| +4% | +$5.2M |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.